Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Chemotherapy Maintenance for Ovarian Cancer
NCT01175772Phase 2Terminated
- Sponsor
- Emek Medical Center
- Start
- Aug 2010
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, celecoxib, methotrexate in ovarian carcinoma, sponsored by Emek Medical Center. Started Aug 2010; status: terminated.
02
Drugs
cyclophosphamidecelecoxibmethotrexate
03
Conditions
ovarian carcinoma
Beyond the preview
Go deeper on NCT01175772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175772.